SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,729.27 413.66
( 0.56%)

Global Indices

Nasdaq

52,191.76 549.28
(1.06%)

Dow Jones

7,764.37 24.43
(0.32%)

Hang Seng

65,489.63 1,063.68
(1.65%)

Nikkei 225

10,840.19 115.33
(1.08%)

Forex

USD-INR

95.08 -0.14
(-0.15%)

EUR-INR

106.23 -0.27
(-0.26%)

GBP-INR

125.74 -0.30
(-0.24%)

JPY-INR

0.60 0.00
(-0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

501.202063

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

17.26

15395.26

EPS(TTM)

Face Value()

Div & Yield %

45.47

0.58

Back

Atmastco consolidated net profit rises 61.36% in the June 2026 quarter

Aug 15,2026

Net profit of Atmastco rose 61.36% to Rs 1.42 crore in the quarter ended June 2026 as against Rs 0.88 crore during the previous quarter ended June 2025. Sales declined 18.58% to Rs 42.73 crore in the quarter ended June 2026 as against Rs 52.48 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	42.73	52.48	-19
OPM %	16.97	7.64	-
PBDT	3.63	2.13	70
PBT	2.30	1.22	89
NP	1.42	0.88	61

74,729.27 413.66 ( 0.56%)

52,191.76 549.28 (1.06%)

7,764.37 24.43 (0.32%)

65,489.63 1,063.68 (1.65%)

10,840.19 115.33 (1.08%)

95.08 -0.14 (-0.15%)

106.23 -0.27 (-0.26%)

125.74 -0.30 (-0.24%)

0.60 0.00 (-0.23%)